167 related articles for article (PubMed ID: 20455597)
41. Distribution of subtypes of metastatic renal-cell carcinoma: correlating findings of fine-needle aspiration biopsy and surgical pathology.
Mai KT; Alhalouly T; Lamba M; Yazdi HM; Stinson WA
Diagn Cytopathol; 2003 Feb; 28(2):66-70. PubMed ID: 12561022
[TBL] [Abstract][Full Text] [Related]
42. Image analysis of proliferating cell nuclear antigen expression and immunohistochemical profiles in renal cell carcinoma associated with acquired cystic kidney disease: comparison with classic renal cell carcinoma.
Khurana KK; Truong LD; Verani RR
Mod Pathol; 1998 Apr; 11(4):339-46. PubMed ID: 9578084
[TBL] [Abstract][Full Text] [Related]
43. Expression of two isozymes of acyl-coenzyme A: cholesterol acyltransferase-1 and -2 in clear cell type renal cell carcinoma.
Matsumoto K; Fujiwara Y; Nagai R; Yoshida M; Ueda S
Int J Urol; 2008 Feb; 15(2):166-70. PubMed ID: 18269457
[TBL] [Abstract][Full Text] [Related]
44. Profiling and classification tree applied to renal epithelial tumours.
Allory Y; Bazille C; Vieillefond A; Molinié V; Cochand-Priollet B; Cussenot O; Callard P; Sibony M
Histopathology; 2008 Jan; 52(2):158-66. PubMed ID: 18036175
[TBL] [Abstract][Full Text] [Related]
45. Identification of CD70 as a diagnostic biomarker for clear cell renal cell carcinoma by gene expression profiling, real-time RT-PCR and immunohistochemistry.
Diegmann J; Junker K; Gerstmayer B; Bosio A; Hindermann W; Rosenhahn J; von Eggeling F
Eur J Cancer; 2005 Aug; 41(12):1794-801. PubMed ID: 16043348
[TBL] [Abstract][Full Text] [Related]
46. Expression of CD9/motility-related protein 1 (MRP-1) in renal parenchymal neoplasms: consistent expression in papillary and chromophobe renal cell carcinomas.
Kuroda N; Inoue K; Guo L; Miyazaki E; Hayashi Y; Naruse K; Toi M; Hiroi M; Shuin T; Enzan H
Hum Pathol; 2001 Oct; 32(10):1071-7. PubMed ID: 11679941
[TBL] [Abstract][Full Text] [Related]
47. Identification of S100A8 and S100A9 as serological markers for colorectal cancer.
Kim HJ; Kang HJ; Lee H; Lee ST; Yu MH; Kim H; Lee C
J Proteome Res; 2009 Mar; 8(3):1368-79. PubMed ID: 19186948
[TBL] [Abstract][Full Text] [Related]
48. Serological and proteomic evaluation of antibody responses in the identification of tumor antigens in renal cell carcinoma.
Unwin RD; Harnden P; Pappin D; Rahman D; Whelan P; Craven RA; Selby PJ; Banks RE
Proteomics; 2003 Jan; 3(1):45-55. PubMed ID: 12548633
[TBL] [Abstract][Full Text] [Related]
49. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
[TBL] [Abstract][Full Text] [Related]
50. Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma.
Griffith TS; Fialkov JM; Scott DL; Azuhata T; Williams RD; Wall NR; Altieri DC; Sandler AD
Cancer Res; 2002 Jun; 62(11):3093-9. PubMed ID: 12036919
[TBL] [Abstract][Full Text] [Related]
51. Comparative membrane proteomics: a technical advancement in the search of renal cell carcinoma biomarkers.
Raimondo F; Corbetta S; Savoia A; Chinello C; Cazzaniga M; Rocco F; Bosari S; Grasso M; Bovo G; Magni F; Pitto M
Mol Biosyst; 2015 Jun; 11(6):1708-16. PubMed ID: 25926002
[TBL] [Abstract][Full Text] [Related]
52. Mucinous tubular and spindle cell carcinoma of kidney and problems in diagnosis.
Sarsik B; Sımşır A; Karaarslan S; Sen S
Turk Patoloji Derg; 2011 May; 27(2):116-26. PubMed ID: 21630197
[TBL] [Abstract][Full Text] [Related]
53. Differential protein profiling of renal cell carcinoma urinary exosomes.
Raimondo F; Morosi L; Corbetta S; Chinello C; Brambilla P; Della Mina P; Villa A; Albo G; Battaglia C; Bosari S; Magni F; Pitto M
Mol Biosyst; 2013 Jun; 9(6):1220-33. PubMed ID: 23511837
[TBL] [Abstract][Full Text] [Related]
54. Upregulation of tissue and urinary nicotinamide N-methyltransferase in bladder cancer: potential for the development of a urine-based diagnostic test.
Sartini D; Muzzonigro G; Milanese G; Pozzi V; Vici A; Morganti S; Rossi V; Mazzucchelli R; Montironi R; Emanuelli M
Cell Biochem Biophys; 2013 Apr; 65(3):473-83. PubMed ID: 23097023
[TBL] [Abstract][Full Text] [Related]
55. L-DOPA decarboxylase mRNA levels provide high diagnostic accuracy and discrimination between clear cell and non-clear cell subtypes in renal cell carcinoma.
Papadopoulos EI; Petraki C; Gregorakis A; Chra E; Fragoulis EG; Scorilas A
Clin Biochem; 2015 Jun; 48(9):590-5. PubMed ID: 25721989
[TBL] [Abstract][Full Text] [Related]
56. Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples.
Raimondo F; Morosi L; Chinello C; Perego R; Bianchi C; Albo G; Ferrero S; Rocco F; Magni F; Pitto M
Mol Biosyst; 2012 Apr; 8(4):1007-16. PubMed ID: 22159573
[TBL] [Abstract][Full Text] [Related]
57. iTRAQ-based quantitative proteomic analysis reveals potential early diagnostic markers of clear-cell Renal cell carcinoma.
Zhang L; Jiang H; Xu G; Chu N; Xu N; Wen H; Gu B; Liu J; Mao S; Na R; Jing Y; Ding Q; Zhang Y; Wang L
Biosci Trends; 2016 Jul; 10(3):210-9. PubMed ID: 27319973
[TBL] [Abstract][Full Text] [Related]
58. Profilin 1 overexpression in renal cell carcinoma.
Minamida S; Iwamura M; Kodera Y; Kawashima Y; Ikeda M; Okusa H; Fujita T; Maeda T; Baba S
Int J Urol; 2011 Jan; 18(1):63-71. PubMed ID: 21091798
[TBL] [Abstract][Full Text] [Related]
59. Amniotic fluid proteome analysis from Down syndrome pregnancies for biomarker discovery.
Cho CK; Smith CR; Diamandis EP
J Proteome Res; 2010 Jul; 9(7):3574-82. PubMed ID: 20459121
[TBL] [Abstract][Full Text] [Related]
60. LC-MS based serum metabonomic analysis for renal cell carcinoma diagnosis, staging, and biomarker discovery.
Lin L; Huang Z; Gao Y; Yan X; Xing J; Hang W
J Proteome Res; 2011 Mar; 10(3):1396-405. PubMed ID: 21186845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
